AI
NVAX icon

Atom Investors’s Novavax NVAX Stock Holding History

Atom Investors’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
38,175
+26,024
+214% +$233K 0.03% 646
2026
Q1 		$98.9K Sell
12,151
-96,017
-89% -$870K 0.01% 624
2025
Q4 		$727K Buy
+108,168
New +$815K 0.06% 347
2025
Q3 		– Sell
-20,439
Closed -$129K – 757
2025
Q2 		$129K Buy
+20,439
New +$135K 0.01% 536
2024
Q3 		– Sell
-12,323
Closed -$156K – 566
2024
Q2 		$156K Sell
12,323
-7,237
-37% -$72.8K 0.02% 435
2024
Q1 		$93.5K Buy
+19,560
New +$90.7K 0.01% 527

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Atom Investors's NVAX Position: Q2 2026 in Review

Atom Investors increased its Novavax (NVAX) stake by 214% in Q2 2026, buying an estimated $233K and bringing the position to 38,175 shares worth $360K. The position accounts for 0.03% of the portfolio, ranked #646.

Atom Investors first reported a position in NVAX in Q1 2024 and has held it in 6 quarters since. The position peaked at $727K in Q4 2025. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Atom Investors held 38,175 shares of Novavax worth $360K as of Q2 2026.
  • Atom Investors bought 26,024 Novavax shares in Q2 2026, an estimated $233K.
  • Novavax made up 0.03% of Atom Investors's portfolio in Q2 2026, its #646 holding.
  • Atom Investors first reported a position in Novavax in Q1 2024 and has held it in 6 quarters since.
  • Atom Investors's Novavax position peaked at $727K in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Atom Investors's 13F filing for Q2 2026, filed 14 Aug 2026.